[综合性瘤学在 (治疗后) 幸存者护理中的作用]
Julia Reusch1,2, Matthias Kröz3,4,5, Tilly Nothhelfer6
1Klinik für Onkologie und Hämatologie, Stadtspital Zürich Triemli, Schweiz.
Therapeutische Umschau. Revue therapeutique
|November 18, 2025
概括
综合性瘤学 (IO) 通过将补充疗法与传统治疗相结合,改善癌症生存率. 这种方法提高了长期损伤的癌症幸存者的福祉和生活质量.
科学领域:
- 在瘤学瘤学.
- 综合医学是一个整体的医学.
- 癌症幸存者 护理 护理
背景情况:
- 由于更好的诊断和治疗方法,癌症幸存者的数量正在增加.
- 与一般人群相比,幸存者经常经历长期的身体,心理和社会障碍.
- 现有的幸存者护理模式不足以应对这些持续存在的挑战.
研究的目的:
- 探索综合性瘤学 (IO) 在增强癌症幸存者护理中的作用.
- 突出结合基于证据的补充疗法与传统癌症治疗的好处.
- 改善癌症幸存者的整体福祉和生活质量.
主要方法:
- 在传统医疗治疗中整合基于证据的补充疗法.
- 利用综合性瘤学的核心学科的干预措施.
- 专注于积极的自我管理策略,包括营养和运动,用于二次预防.
主要成果:
- IO可以减少常见的幸存者问题,如与癌症相关的疲劳,睡眠障碍和化疗诱导的多神经病变.
- 整合IO概念可以提高癌症幸存者的生活质量 (QoL).
- IO的干预措施可以是互补的,协作性的,并与标准医疗保健一起透明地应用.
结论:
- 综合性瘤学为解决癌症幸存者护理的未满足需求做出了重大贡献.
- IO提高了患者的福祉,并促进了癌症幸存者的积极自我管理.
- IO疗法提供了一个有价值的框架,可以改善癌症后生活的个体的长期结果和生活质量.
关键词:
在CIPN中,您可以使用CIPN.幸存者的生存方式运动就是炼身体.疲劳 疲劳 疲劳 疲劳 疲劳 疲劳失眠是因为失眠.综合性瘤学是一个综合性瘤学.营养 营养 营养 营养睡眠障碍 睡眠障碍 睡眠障碍更多相关视频
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633


